ペンニードルの世界市場:タイプ別、治療別2023年予測
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023
- 出版元:MarketsandMarkets出版元について
- 発行年:2019年 2月
- 定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算(お見積り日TTSレート)となります。
- 納品形態:PDF by Email
- 当調査レポートは英文 145ページになります。
- 商品コード:MAM1447
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
ペンニードルの世界市場規模は2018年の20億ドルから、今後2023年には34億ドルに達すると予測されます。
当レポートでは、2023年に至るペンニードルの世界市場予測(市場規模US$、数量Units)、タイプ別市場(スタンダード、セーフティ)、長さ別市場(4mm、5mm、6mm、8mm、10mm、12mm)、治療別市場(インスリン、GLP-1、成長ホルモン、その他)、販売形態別市場(小売、小売以外)、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業12社プロフィール動向などの情報も交えて、ペンニードル市場の現在と今後展開を予測分析していきます。
【レポート構成概要】
◆ペンニードルの世界市場予測2016-2023年
・市場規模(US$)
・数量(Units)
◆タイプ別、市場-2023年
・スタンダード
・セーフティ
※(市場規模US$、数量Units)
◆長さ別、市場-2023年
・4mm
・5mm
・6mm
・8mm
・10mm
・12mm
※(市場規模US$)
◆治療別、市場-2023年
・インスリン
・GLP-1(グルカゴン様ペプチド-1)
・成長ホルモン
・その他
※(市場規模US$)
◆販売形態別、市場-2023年
・小売
・小売以外
※(市場規模US$)
◆主要国地域別市場-2023年
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
北米
・米国、カナダ
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
・中南米
・中東アフリカ
※地域別に、全セグメント別の細分化データ掲載、詳細は目次参照
※国別に、タイプ別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・業界構造分析(ファイブフォース分析)
・競合状況
◆ペンニードルの主要企業プロフィール動向
・BECTON, DICKINSON AND COMPANY
・NOVO NORDISK
・YPSOMED
・OWEN MUMFORD, LTD.
・HTL-STREFA
・B. BRAUN MELSUNGEN
・テルモ株式会社
・ULTIMED
・ALLISON MEDICAL, INC.
・ARTSANA S.P.A.
・アークレイ株式会社
・GLUCORX
(全125頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023
Table of Contents
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED.. 16
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
2.2 MARKET SIZE ESTIMATION
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION
2.3 ASSUMPTIONS FOR THE STUDY
3.... EXECUTIVE SUMMARY
4.... PREMIUM INSIGHTS
4.1 PEN NEEDLES MARKET OVERVIEW
4.2 EUROPE: PEN NEEDLES MARKET, BY TYPE & COUNTRY, 2018
4.3 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2018
4.4 PEN NEEDLES MARKET: GEOGRAPHIC SNAPSHOT
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 GROWING PREVALENCE OF CHRONIC DISEASES
5.2.1.2 FAVORABLE REIMBURSEMENT IN SELECTED COUNTRIES
5.2.2 RESTRAINTS
5.2.2.1 PREFERENCE FOR ALTERNATIVE MODES OF DRUG DELIVERY
5.2.2.2 POOR REIMBURSEMENT SCENARIO IN DEVELOPING COUNTRIES
5.2.3 OPPORTUNITIES
5.2.3.1 GROWING PREFERENCE FOR BIOSIMILAR DRUGS
5.2.4 CHALLENGES
5.2.4.1 REUSE OF PEN NEEDLES
6.... INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 PORTER’S FIVE FORCES ANALYSIS
6.2.1 THREAT OF NEW ENTRANTS
6.2.2 BARGAINING POWER OF SUPPLIERS
6.2.3 BARGAINING POWER OF BUYERS
6.2.4 SEGMENT RIVALRY. 40
6.2.5 THREAT OF SUBSTITUTES
6.3 COMPETITIVE INTENSITY
6.3.1 EVALUATION PARAMETERS
6.3.2 SCORING METHODOLOGY
6.3.3 COMPETITIVE INTENSITY SCORE, BY COMPANY
6.3.3.1 COMPETITIVE INTENSITY SCORE FOR BD
6.3.3.2 COMPETITIVE INTENSITY SCORE FOR NOVO NORDISK
6.3.3.3 COMPETITIVE INTENSITY SCORE FOR YPSOMED
6.3.4 COMPETITIVE INTENSITY MAPPING OF BD, NOVO NORDISK, AND YPSOMED
6.3.5 COMPARISON OF EVALUATION PARAMETERS, BY COMPANY
6.3.5.1 PRICING
6.3.5.2 PRODUCT PORTFOLIO
6.3.5.3 PRODUCT LAUNCHES/TECHNOLOGICAL ADVANCEMENTS
6.3.5.4 GEOGRAPHICAL PRESENCE
6.3.5.5 PROMOTIONAL/MARKETING ACTIVITIES
6.3.5.6 SPONSORSHIPS/DONATIONS/EDUCATION/AWARENESS CAMPAIGNS
6.3.5.7 M&A, PARTNERSHIPS, COLLABORATIONS, AGREEMENTS, AND EXPANSIONS. 54
6.3.5.8 CERTIFICATIONS/ACCREDITATIONS/AWARDS
7.... PEN NEEDLES MARKET, BY TYPE
7.1 INTRODUCTION
7.2 STANDARD PEN NEEDLES
7.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE, CONSIDERING THE NEED FOR DAILY INSULIN INTAKE
7.3 SAFETY PEN NEEDLES
7.3.1 DEMAND FOR SAFETY PEN NEEDLES TO RISE DUE TO GROWING CONCERNS REGARDING THE PREVENTION OF NSIS ASSOCIATED WITH STANDARD NEEDLES
8.... PEN NEEDLES MARKET, BY LENGTH
8.1 INTRODUCTION
8.2 4MM
8.2.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
8.3 5MM
8.3.1 5MM PEN NEEDLES TO REGISTER THE SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD
8.4 6MM
8.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE
8.5 8MM
8.5.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
8.6 10MM
8.6.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET
8.7 12MM
8.7.1 POPULARITY OF SHORTER & LESS PAINFUL NEEDLES TO HAMPER THE GROWTH OF THE 12MM PEN NEEDLES MARKET
9.... PEN NEEDLES MARKET, BY THERAPY
9.1 INTRODUCTION
9.2 INSULIN THERAPY
9.2.1 RISING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY. 70
9.3 GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY
9.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS IN THE MARKET TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR GLP-1 THERAPY
9.4 GROWTH HORMONE THERAPY
9.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY
9.5 OTHER THERAPIES
10.. PEN NEEDLES MARKET, BY MODE OF PURCHASE
10.1 INTRODUCTION
10.2 RETAIL
10.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES
10.3 NON-RETAIL
10.3.1 THE LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT
11.. PEN NEEDLES MARKET, BY REGION
11.1 INTRODUCTION
11.2 EUROPE
11.2.1 GERMANY
11.2.1.1 HIGH DIABETES EXPENDITURE AND REIMBURSEMENT FOR PEN NEEDLES IS EXPECTED TO DRIVE THE MARKET IN GERMANY
11.2.2 UK
11.2.2.1 NHS SUPPORT AND ACCESS TO COST-EFFECTIVE PEN NEEDLES ARE LIKELY TO DRIVE THE MARKET IN THE UK
11.2.3 FRANCE
11.2.3.1 HIGHER INSURANCE COVERAGE AND INCREASE IN AGING POPULATION AND AFFORDABILITY CONTRIBUTE TO DEMAND FOR PEN NEEDLES
11.2.4 ITALY
11.2.4.1 WIDE REGIONAL VARIATIONS IN TERMS OF BENEFITS AND COVERAGE TO SLOW GROWTH IN ITALY
11.2.5 SPAIN
11.2.5.1 SUPPORTIVE REGULATIONS MANDATING THE USE OF SAFETY PEN NEEDLES TO BOOST THE GROWTH OF THE SPANISH MARKET
11.2.6 REST OF EUROPE
11.3 NORTH AMERICA
11.3.1 US
11.3.1.1 US DOMINATES THE PEN NEEDLES MARKET IN NORTH AMERICA
11.3.2 CANADA
11.3.2.1 HIGH DIABETES PREVALENCE AND GROWING GERIATRIC POPULATION WILL SUPPORT PEN NEEDLE UPTAKE
11.4 ASIA PACIFIC
11.4.1 JAPAN
11.4.1.1 HIGH DIABETES INCIDENCE AND APPROVAL OF INJECTABLE INSULIN TO DRIVE THE PEN NEEDLES MARKET IN JAPAN
11.4.2 CHINA
11.4.2.1 SUBOPTIMAL INSURANCE COVERAGE POLICIES WILL DAMPEN MARKET GROWTH
11.4.3 INDIA
11.4.3.1 LOW PEN NEEDLE PENETRATION, LACK OF AWARENESS TO RESTRAIN MARKET GROWTH IN INDIA
11.4.4 REST OF ASIA PACIFIC
11.5 REST OF THE WORLD
11.5.1 LATIN AMERICA
11.5.1.1 HEALTHCARE REFORMS TO DRIVE GROWTH IN MEXICO
11.5.2 MIDDLE EAST & AFRICA
11.5.2.1 FAVORABLE REFORMS IN SOUTH AFRICA TO BOLSTER MARKET GROWTH
12.. COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE (AS OF 2017)
12.2.1 BECTON, DICKINSON AND COMPANY
12.2.2 NOVO NORDISK
12.2.3 YPSOMED
12.3 COMPETITIVE LEADERSHIP MAPPING (2017)
12.3.1 VENDOR INCLUSION CRITERIA
12.3.2 VISIONARY LEADERS
12.3.3 INNOVATORS
12.3.4 DYNAMIC DIFFERENTIATORS
12.3.5 EMERGING COMPANIES
12.4 COMPETITIVE SCENARIO
12.4.1 PRODUCT LAUNCHES
12.4.2 EXPANSIONS
12.4.3 AGREEMENTS
13.. COMPANY PROFILES
(INTRODUCTION, PRODUCTS & SERVICES, STRATEGY, & ANALYST INSIGHTS, DEVELOPMENTS, MNM VIEW)*
13.1 BECTON, DICKINSON AND COMPANY
13.2 NOVO NORDISK
13.3 YPSOMED
13.4 OWEN MUMFORD, LTD.
13.5 HTL-STREFA
13.6 B. BRAUN MELSUNGEN
13.7 TERUMO CORPORATION
13.8 ULTIMED
13.9 ALLISON MEDICAL, INC.
13.10 ARTSANA S.P.A.
13.11 ARKRAY, INC.
13.12 GLUCORX
*DETAILS ON MARKETSANDMARKETS VIEW, INTRODUCTION, PRODUCT & SERVICES, STRATEGY, & ANALYST INSIGHTS, NEW DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14.. APPENDIX
LIST OF TABLES
TABLE 1 EVALUATION PARAMETERS & SCORES
TABLE 2 COMPETITIVE INTENSITY FOR BD
TABLE 3 COMPETITIVE INTENSITY FOR NOVO NORDISK
TABLE 4 COMPETITIVE INTENSITY FOR YPSOMED
TABLE 5 PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 6 PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 7 STANDARD PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 8 STANDARD PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS)
TABLE 9 SAFETY PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 10 SAFETY PEN NEEDLES MARKET, BY REGION, 2016–2023 (THOUSAND UNITS)
TABLE 11 PEN NEEDLES MARKET, BY LENGTH, 2016–2023 (USD MILLION)
TABLE 12 4MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 13 5MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 14 6MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 15 8MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 16 10MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 17 12MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 18 PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION)
TABLE 19 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY REGION,
2016–2023 (USD MILLION)
TABLE 20 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY REGION,
2016–2023 (USD MILLION)
TABLE 21 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY,
BY REGION, 2016–2023 (USD MILLION)
TABLE 22 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY REGION,
2016–2023 (USD MILLION)
TABLE 23 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016–2023 (USD MILLION)
TABLE 24 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY REGION,
2016–2023 (USD MILLION)
TABLE 25 INDICATIVE LIST OF REGULATORY ACTS
TABLE 26 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY REGION,
2016–2023 (USD MILLION)
TABLE 27 PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 28 PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS)
TABLE 29 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 30 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (MILLION UNITS)
TABLE 31 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 32 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 33 EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016–2023 (USD MILLION)
TABLE 34 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION)
TABLE 35 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION)
TABLE 36 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 37 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 38 UK: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 39 UK: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 40 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 41 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 42 ITALY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 43 ITALY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 44 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 45 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 46 ROE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 47 ROE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 48 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION)
TABLE 49 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2016–2023 (MILLION UNITS)
TABLE 50 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 51 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 52 NORTH AMERICA: PEN NEEDLES MARKET, BY NEEDLE LENGTH,
2016–2023 (USD MILLION)
TABLE 53 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2016–2023 (USD MILLION)
TABLE 54 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION)
TABLE 55 US: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 56 US: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 57 CANADA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 58 CANADA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 59 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 60 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (MILLION UNITS)
TABLE 61 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 62 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 63 ASIA PACIFIC: PEN NEEDLES MARKET, BY NEEDLE LENGTH,
2016–2023 (USD MILLION)
TABLE 64 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION)
TABLE 65 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION)
TABLE 66 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 67 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 68 CHINA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 69 CHINA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 70 INDIA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 71 INDIA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS)
TABLE 72 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 73 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (THOUSAND UNITS)
TABLE 74 ROW: PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 75 ROW: PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS)
TABLE 76 ROW: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 77 ROW: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (THOUSAND UNITS)
TABLE 78 ROW: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016–2023 (USD MILLION)
TABLE 79 ROW: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION)
TABLE 80 ROW: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION)
TABLE 81 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 82 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (THOUSAND UNITS)
TABLE 83 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (USD MILLION)
TABLE 84 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (THOUSAND UNITS)
TABLE 85 PRODUCT LAUNCHES
TABLE 86 EXPANSIONS
TABLE 87 AGREEMENTS
LIST OF FIGURES
FIGURE 1 PEN NEEDLES MARKET SEGMENTATION
FIGURE 2 PEN NEEDLES MARKET: RESEARCH METHODOLOGY
FIGURE 3 RESEARCH DESIGN
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 PEN NEEDLES MARKET, BY TYPE, 2018
FIGURE 9 PEN NEEDLES MARKET, BY LENGTH, 2018–2023
FIGURE 10 PEN NEEDLES MARKET, BY THERAPY, 2018–2023
FIGURE 11 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2018
FIGURE 12 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET, 2018
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET
FIGURE 14 STANDARD PEN NEEDLES TO DOMINATE THE EUROPEAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD
FIGURE 15 STANDARD PEN NEEDLES TO DOMINATE THE NORTH AMERICAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD
FIGURE 16 ASIA PACIFIC IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 17 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: PEN NEEDLES MARKET
FIGURE 19 SCORING METHODOLOGY
FIGURE 20 COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK,
AND YPSOMED
FIGURE 21 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS
FIGURE 22 SAFETY PEN NEEDLES BY BD AND STANDARD PEN NEEDLES BY NOVO NORDISK ARE PREMIUM-PRICED
FIGURE 23 BD HAS A ROBUST PORTFOLIO OF BOTH STANDARD AND SAFETY PEN NEEDLES
FIGURE 24 BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS
FIGURE 25 BD AND NOVO NORDISK HAVE A STRONG GEOGRAPHIC PRESENCE
FIGURE 26 BD AND NOVO NORDISK SHOWCASE HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES
FIGURE 27 NOVO NORDISK HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS
FIGURE 28 NOVO NORDISK AGGRESSIVELY FOLLOWS THE STRATEGIES OF PARTNERSHIPS & AGREEMENTS
FIGURE 29 BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS
FIGURE 30 STANDARD PEN NEEDLES TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
FIGURE 31 8MM PEN NEEDLES SEGMENT ACCOUNTED FOR THE LARGEST MARKET
SHARE IN 2018
FIGURE 32 INSULIN THERAPY SEGMENT TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET IN 2018
FIGURE 33 RETAIL SEGMENT WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
FIGURE 34 EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PEN NEEDLES MARKET IN 2018 81
FIGURE 35 EUROPE: PEN NEEDLES MARKET SNAPSHOT
FIGURE 36 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
FIGURE 37 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT
FIGURE 38 REST OF WORLD: PEN NEEDLES MARKET SNAPSHOT
FIGURE 39 PEN NEEDLES MARKET SHARE (AS OF 2017)
FIGURE 40 MNM DIVE-VENDOR COMPARISON MATRIX: PEN NEEDLES MARKET
FIGURE 41 STRATEGIES ADOPTED BY MARKET PLAYERS (2015-2018)
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 43 NOVO NORDISK: COMPANY SNAPSHOT
FIGURE 44 YPSOMED: COMPANY SNAPSHOT
FIGURE 45 B.BRAUN: COMPANY SNAPSHOT
FIGURE 46 TERUMO: COMPANY SNAPSHOT
掲載企業リスト
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。